|
|
Post by JHam on Jun 25, 2015 10:22:56 GMT
|
|
|
|
Post by fly2belgium on Jun 25, 2015 17:09:12 GMT
You think this is a voluntarily exit or was she guided to the door?
The new CFO seems quite experienced.
|
|
|
|
Post by furbush87 on Jun 25, 2015 19:18:09 GMT
You think this is a voluntarily exit or was she guided to the door? The new CFO seems quite experienced. voluntary. no reason to suspect otherwise |
|
|
|
Post by JHam on Jun 26, 2015 1:01:45 GMT
You think this is a voluntarily exit or was she guided to the door? The new CFO seems quite experienced. From the 8-K: ir.oncosec.com/all-sec-filings/content/0001104659-15-047688/a15-14755_18k.htmItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Departure of Chief Financial Officer
On June 24, 2015, Veronica Vallejo resigned from her position as Chief Financial Officer (and principal financial officer) of OncoSec Medical Incorporated (the “Company”). The Company and Ms. Vallejo have entered into a Termination and Separation Agreement pursuant to which the Company agreed to pay Ms. Vallejo severance of $309,833 (which includes 30 days pay in lieu of notice under her employment agreement), less applicable withholdings, in the form of salary continuation in accordance with the Company’s customary payroll practices and a pro rata portion of her bonus for 2015 equal to $35,100. Ms. Vallejo signed a release in favor of the Company (subject to her statutory rights). The Company has also agreed to accelerate the vesting of 31,586 stock options held by Ms. Vallejo as of the date of her termination, and to extend the exercise period for one (1) year post-termination for all of her vested stock options. |
|
|
|
Post by happyjawa on Jun 26, 2015 6:02:28 GMT
You think this is a voluntarily exit or was she guided to the door? The new CFO seems quite experienced. From the 8-K: ir.oncosec.com/all-sec-filings/content/0001104659-15-047688/a15-14755_18k.htmItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Departure of Chief Financial Officer
On June 24, 2015, Veronica Vallejo resigned from her position as Chief Financial Officer (and principal financial officer) of OncoSec Medical Incorporated (the “Company”). The Company and Ms. Vallejo have entered into a Termination and Separation Agreement pursuant to which the Company agreed to pay Ms. Vallejo severance of $309,833 (which includes 30 days pay in lieu of notice under her employment agreement), less applicable withholdings, in the form of salary continuation in accordance with the Company’s customary payroll practices and a pro rata portion of her bonus for 2015 equal to $35,100. Ms. Vallejo signed a release in favor of the Company (subject to her statutory rights). The Company has also agreed to accelerate the vesting of 31,586 stock options held by Ms. Vallejo as of the date of her termination, and to extend the exercise period for one (1) year post-termination for all of her vested stock options.Wow. |
|
|
|
Post by JHam on Jun 26, 2015 11:56:20 GMT
|
|
|
|
Post by furbush87 on Jun 26, 2015 13:06:37 GMT
I'm not going to spend the time looking for her employment contract, but that is certainly a valid theory, another valid one is that she may be located in Washington and is unwilling/unable to make the move to San Diego, as a result of them moving her job, she gets a nice severance. Moot point either way. |
|
|
|
Post by JHam on Jun 26, 2015 14:07:13 GMT
I'm not going to spend the time looking for her employment contract, but that is certainly a valid theory, another valid one is that she may be located in Washington and is unwilling/unable to make the move to San Diego, as a result of them moving her job, she gets a nice severance. Moot point either way. It is moot and we'll never know anyway...unless she pops up in a PR for accepting a new job in the next few days. |
|
|
|
Post by furbush87 on Jul 11, 2015 12:26:00 GMT
I'm not going to spend the time looking for her employment contract, but that is certainly a valid theory, another valid one is that she may be located in Washington and is unwilling/unable to make the move to San Diego, as a result of them moving her job, she gets a nice severance. Moot point either way. It is moot and we'll never know anyway...unless she pops up in a PR for accepting a new job in the next few days. So question about the recent form 3 and 4s filed. Slansky bough 5k shares prior to his start date of July 8th (bough 6/22), then a form 4 is filed, the transaction code P means it was bought on open market, but the footnote 1 talks about options vesting 90 days from 7/6. Is this a buy, an options award? |
|
